AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
UCL Trial Tests Whether AI Can Improve Prostate MRI Cancer Diagnosis
University College London is launching a trial to test AI in prostate MRI diagnosis, another sign that prostate imaging remains a major proving ground for clinical AI. The study will help answer whether models can improve accuracy and consistency without slowing down specialist workflows.
DeepHealth wins FDA clearance for prostate AI, signaling momentum in urologic imaging
RadNet subsidiary DeepHealth has received FDA clearance for a prostate AI solution, adding to the growing list of urology-focused diagnostic tools reaching the U.S. market. The clearance suggests regulators remain open to targeted AI products when developers can show a defined clinical role.
FDA Breakthrough Designation for AI Bladder Cancer Test Signals Continued Momentum in Urologic Diagnostics
The FDA granted breakthrough designation to an AI-based bladder cancer prognostic test, adding to a growing cluster of regulatory wins in this disease area. The move suggests the agency remains receptive to tools that promise better risk stratification, even as it sharpens scrutiny around validation and clinical utility.
FDA Grants Breakthrough Status to Vesta Bladder Risk Test as Urology AI Race Intensifies
Vesta’s bladder risk stratification test has earned FDA breakthrough device designation, reinforcing how quickly AI-powered urology products are moving into the regulatory spotlight. The designation may speed development, but it also raises the stakes for proving real-world impact beyond model performance.
Valar Labs’ New Breakthrough Designation Highlights Momentum in AI Risk Stratification
Valar Labs has received FDA Breakthrough Device Designation for its bladder risk stratification diagnostic, giving the company a regulatory boost. The designation suggests growing confidence in AI tools that help clinicians prioritize risk rather than make final diagnoses.
AI Test for Bladder Cancer Gets FDA Breakthrough Designation, Boosting Momentum in Urologic Diagnostics
An AI test for bladder cancer has received FDA Breakthrough Device Designation, a status that can speed development and review for promising technologies. The designation adds to a wave of regulatory momentum around AI-powered diagnostics, especially in oncology and risk stratification.
Prostate Cancer AI Is Gaining Ground as Clinicians Push for Faster Diagnosis
Kennesaw State University and a separate clinician-focused interview highlight growing momentum around AI for prostate cancer diagnosis. The story reflects a broader push to use emerging technologies to speed up detection and improve decision-making in a high-volume cancer pathway.
Prostate MRI Becomes the Next Practical Beachhead for Radiology AI
Cleveland Clinic’s look at AI in prostate MRI underscores how the technology is being positioned as a practical aid for one of radiology’s more variable and expertise-sensitive exams. The opportunity is less about replacing readers and more about standardizing interpretation, reducing misses, and improving workflow consistency.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.